International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7956615
Original Article
Maternal and Fetal Outcome of Placenta Previa in a Tertiary Care Hospital
 ,
Published
May 22, 2023
Abstract
Introduction: Placenta previa (PP) is an important cause of maternal and fetal morbidity and mortality worldwide. It is one of the major cause for antepartum heamorrhage which complicates 1-5% of the pregnancies. Aim: To determine the incidence and maternal and fetal outcomes among women with placenta previa (PP). Methods: This is retrospective, observational study carried out in Department of Obstetrics &Gynaecology of T.N.M.C & BYL Ch. Nair hospital, Mumbai over a period of 2years from January 1st2018 to December 31st 2019. Results: Total number of patients delivered during this period were 6290 and out of which 94 patients were diagnosed with placenta previa, so the incidence is 1.5%. Of women with placenta previa, 3.44%(n=4) had placenta accreta. Incidence of placenta previa was the highest in the maternal age group 20-30 years i.e. 72.9%, Perinatal morbidity was studied as the percentage of babies requiring resuscitation and NICU admission which was 37.35 %(n=36). Caesarean hysterectomy was performed in 10.4% (n=10) cases, there were 1.72 %(n=2) perinatal deaths.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2711 Views
161 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved